LAPURON Aurora Super PDRN in Pakistan: Formula, Evidence, Alternatives and Buying Guide
LAPURON Aurora Super is a professional skin-booster product listed by Starpharmtec as two 2.5 mL syringes containing PDRN 2% and hyaluronic acid 1%.
Those composition and presentation details are manufacturer claims; independent product-specific trials were not located for this guide. Broader polynucleotide evidence is promising but low-to-moderate quality, so clinical expectations should remain measured.
Catalogue visual: LAPURON Aurora Super PDRN from the NEES Medical product catalogue. Packaging appearance alone does not establish authenticity; verify the supplied batch, expiry, seals and traceability documents.
What it is
Starpharmtec's LAPUROON product page identifies Aurora Super as a high-content PDRN and HA formulation in a two-syringe presentation. PDRN is a mixture of DNA fragments used in regenerative-medicine research, while HA is a water-binding polysaccharide used in multiple topical and injectable product categories.
The exact legal classification, authorized route and intended use can differ by market. A catalogue term such as skin booster does not by itself establish that a product is approved for injection in Pakistan, and this guide does not provide administration instructions.
Market position and alternatives
Aurora Super is positioned at the higher-concentration end of the LAPUROON Aurora range. Clinics should compare verified formulation, presentation, route, evidence and local authorization rather than assume that all PDRN or polynucleotide products are interchangeable.
| Option | Manufacturer or category description | Main comparison point |
|---|---|---|
| LAPURON Aurora Super | Starpharmtec lists PDRN 2% plus HA 1% in two 2.5 mL syringes. | Confirm the exact pack, route, local regulatory status and lot documentation. |
| LAPURON Aurora Vivid | Starpharmtec lists PDRN 0.2% plus HA 1% in five 5 mL vials. | Different concentration and packaging make it a separate product, not a cheaper unit-for-unit substitute. |
| Other PN or PDRN products | Polynucleotide-based products with varying source, molecular profile, concentration and evidence. | Do not transfer claims or protocols between brands without label and evidence support. |
| HA-only skin boosters or PRP | Different material or autologous procedure used for skin-quality objectives. | Mechanism, evidence, regulatory classification, reversibility and risk differ. |
Potential advantages
- Starpharmtec publishes a clear Aurora Super concentration and pack presentation for procurement comparison.
- The combination format brings PDRN and HA into one manufacturer-described product rather than requiring a clinic to infer compatibility between separate products.
- A 2025 systematic review found promising polynucleotide outcomes for wrinkles, texture and elasticity across a small evidence base.
- A lot-level procurement record can connect each syringe to its carton, expiry, invoice and supplier documentation.
Limitations and buying considerations
- The systematic review found only nine low- or moderate-quality studies involving 219 patients, with variation in products and procedures.
- No strong independent clinical trial for the exact LAPURON Aurora Super formulation was located, so broader PDRN findings should not be treated as product proof.
- The official product page's benefits are manufacturer positioning and should not be presented as certain clinical outcomes.
- The exact authorized route and Pakistan regulatory status must be documented before professional use.
- The cited public sources do not verify NEES Medical as a product-specific authorized LAPUROON distributor.
Quality and authenticity checklist
- Confirm that the carton identifies LAPUROON Aurora Super and the 2.5 mL × 2 syringe presentation.
- Match printed PDRN and HA composition, batch, expiry and syringe identifiers to the outer pack.
- Inspect seals and sterile barriers and follow the exact temperature and handling statement on the product label.
- Request a dated invoice, supplier or importer identity and applicable Pakistan regulatory documentation.
- Verify questionable packaging or codes with Starpharmtec or the official LAPUROON contact rather than relying on a reseller's image.
Price and availability in Pakistan
LAPURON Aurora Super PDRN pricing in Pakistan requires a current quotation. The quote should identify the 2.5 mL × 2 syringe pack, batch, expiry, stock status, handling requirements and supporting documents.
Searches for lapuroon often refer to the LAPUROON brand spelling. Confirm the full product name because Aurora Super and Aurora Vivid have different published concentrations and pack formats.
Clinical safety: LAPURON Aurora Super is a professional product whose route, suitability and use must be determined by a licensed practitioner from the exact local label and applicable regulation. Direct all patient-specific, prescribing, procedural and administration questions to an appropriately qualified, licensed healthcare professional.
Sources and further reading
- Starpharmtec — official LAPUROON product page
- LAPUROON — official brand website
- PubMed — systematic review of polynucleotides in aesthetic medicine
- DRAP — medical-device establishment licensing overview
View the LAPURON Aurora Super PDRN catalogue page or request current pricing and availability.
Frequently Asked Questions
What is the LAPURON Aurora Super PDRN price in Pakistan?
A current quotation is required. Confirm that it is for Aurora Super in the manufacturer-listed two-syringe presentation and ask for batch, expiry, stock and regulatory documents.
What does the manufacturer list in Aurora Super?
Starpharmtec lists PDRN 2% and HA 1% in two 2.5 mL syringes. Verify the physical pack because formulations and market presentations can change.
How can a clinic verify genuine LAPURON Aurora Super?
Match the complete product name, two-syringe presentation, composition, carton-and-syringe batch details, expiry, seals, invoice and local supplier documents, then query discrepancies through an official brand or manufacturer contact.
How should Aurora Super be stored and what is its shelf life?
Follow the exact unopened carton and insert because this guide did not find a sufficiently clear official public storage specification. The pack-specific expiry and documented handling history control whether stock is acceptable.
When should results be visible?
There is no well-established product-specific timeline from high-quality independent trials. A licensed practitioner should set expectations based on the authorized use, baseline skin and the complete treatment plan.
Is LAPURON Aurora Super the same as Aurora Vivid?
No. Starpharmtec lists different concentrations and packaging: Aurora Super at PDRN 2% plus HA 1% in two 2.5 mL syringes, and Aurora Vivid at PDRN 0.2% plus HA 1% in five 5 mL vials.
About NEES Medical
Latest Posts
